Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001543256-14-000001
Filing Date
2014-04-24
Accepted
2014-04-24 14:27:44
Documents
1
Effectiveness Date
2014-04-24
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12200
  Complete submission text file 0001543256-14-000001.txt   13307
Mailing Address ATTN: WILLIAM HEARL, 313 W. LIBERTY ST. SUITE 343 LANCASTER PA 17603
Business Address ATTN: WILLIAM HEARL, 313 W. LIBERTY ST. SUITE 343 LANCASTER PA 17603 717-327-1919
Immunomic Therapeutics, Inc. (Filer) CIK: 0001543256 (see all company filings)

EIN.: 203878827 | State of Incorp.: DE | Fiscal Year End: 1212
Type: D | Act: 33 | File No.: 021-216208 | Film No.: 14781294